Ivy Quarterly Review | Mackenzie Investments

Ivy Quarterly Review

Highlights from the Third Quarter Edition


A resource for both advisors and investors, the Ivy Quarterly gives perspective on the portfolios, investment philosophy and holdings in a comprehensive format. The Ivy Team discusses world markets and where they are finding value today.

Ivy Quarterly map

Why do we often write about central banks and the price-distorting effects of quantitative easing (QE)? We talk about it to help our clients understand why asset prices keep rising and why we refuse to fully partake in this central-bank-driven stock market mania. Markets are not being driven higher by strong economic fundamentals, which in turn lead to strong sales and earnings growth for businesses. Rather, stocks are rising because of actions by central banks through the portfolio effect of QE and by debt – i.e., poor fundamentals. Therefore, stock markets are extremely expensive. All of our funds have large cash weightings as we attempt to strike the tricky balance of participating in enough of the upmarket to keep our clients moving forward, but not risking losing most of their money if the markets experience another severe downturn.

Historically, the Mackenzie Ivy Funds have experienced poor short-term performance in the first 18 months of a bull market as confidence is restored and poorer quality/more cyclical companies soar. Similarly, we tend to underperform towards the end of a bull market. As complacency increases and markets go parabolic, we become even more careful and thus fall behind. However, we should caution that our poor performance over the last year does not necessarily suggest that the end of the current bull market is imminent. The great differentiator this time is central banks’ explicit involvement in driving asset prices higher, and that could go on far longer than anyone imagined. On the other hand, it could end tomorrow. No one knows. But the longer it goes on, the more difficult it will be to convince people about what is really happening and why they should be increasingly careful. Complacency, greed and rationalization dominate, and caution is abandoned. It’s a pattern that has been repeated time and time again and it will not end as long as central banks are allowed to continue to distort price discovery.

In this Ivy Quarterly Review, we attempt to explain how central banks are driving stock markets higher and how the pernicious effects of inflation and QE distort price discovery, impair economic fundamentals and transfer wealth, resulting in increasing wealth/income disparity.

Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated.

The content of this page (including facts, views, opinions, recommendations, descriptions of or references to, products or securities) is not to be used or construed as investment advice, as an offer to sell or the solicitation of an offer to buy, or an endorsement, recommendation or sponsorship of any entity or security cited. Although we endeavour to ensure its accuracy and completeness, we assume no responsibility for any reliance upon it.

This document includes forward-looking information that is based on forecasts of future events as of September 30, 2017. Mackenzie Financial Corporation will not necessarily update the information to reflect changes after that date. Forward-looking statements are not guarantees of future performance and risks and uncertainties often cause actual results to differ materially from forward-looking information or expectations. Some of these risks are changes to or volatility in the economy, politics, securities markets, interest rates, currency exchange rates, business competition, capital markets, technology, laws, or when catastrophic events occur. Do not place undue reliance on forward-looking information.  In addition, any statement about companies is not an endorsement or recommendation to buy or sell any security.